534 results on '"Foekens, John A."'
Search Results
2. Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
3. Complex landscapes of somatic rearrangement in human breast cancer genomes
4. Tumour radiosensitivity is associated with immune activation in solid tumours
5. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
6. T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression
7. Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor
8. Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
9. GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease
10. An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer
11. Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes
12. A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
13. Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
14. Co-regulated gene expression of splicing factors as drivers of cancer progression
15. Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer
16. Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients
17. Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons
18. Understanding drugs in breast cancer through drug sensitivity screening
19. Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation
20. Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant
21. DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells
22. Clinical value of circulating endothelial cell detection in oncology
23. Optimized nLC-MS workflow for laser capture microdissected breast cancer tissue
24. CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes
25. Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences
26. Identification, validation and clinical implementation of cancer biomarkers: Translational strategies of the EORTC PathoBiology Group
27. Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers
28. Four miRNAs Associated with Aggressiveness of Lymph Node-Negative, Estrogen Receptor-Positive Human Breast Cancer
29. Lung Metastasis Genes Couple Breast Tumor Size and Metastatic Spread
30. Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice
31. Landscape of somatic mutations in 560 breast cancer whole-genome sequences
32. 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
33. Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
34. Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease
35. mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients
36. Proper genomic profiling of (BRCA1-mutated) basal-like breast carcinomas requires prior removal of tumor infiltrating lymphocytes
37. Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
38. Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting
39. Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen
40. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer
41. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes
42. Proteomics Pipeline for Biomarker Discovery of Laser Capture Microdissected Breast Cancer Tissue
43. Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
44. Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer
45. Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes
46. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146
47. MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer
48. Young age, increased tumor proliferation and FOXM1 expression predict early metastatic relapse only for endocrine-dependent breast cancers
49. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine
50. Four human breast cancer cell lines with biallelic inactivating α-catenin gene mutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.